• Journal Article

A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3

Citation

Erickson, S. W., Stephens, O. W., Chavan, S. S., Epstein, J., Barlogie, B., Heuck, C. J., & Vangsted, A. J. (2016). A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3. British Journal of Haematology, 174(6), 991-993. DOI: 10.1111/bjh.13830, 10.1111/bjh.13830

Abstract